Robert Burns
Stock Analyst at H.C. Wainwright
(4.89)
# 293
Out of 4,651 analysts
1051
Total ratings
52%
Success rate
25.5%
Average return
Main Sectors:
Stocks Rated by Robert Burns
| Stock | Action | Price Target | Current | Upside | Ratings | Updated | |
|---|---|---|---|---|---|---|---|
| ZYME Zymeworks | Reiterated: Buy | $51 | $25.12 | +103.03% | 45 | Aug 10, 2026 | |
| ACET Adicet Bio | Reiterated: Buy | $27 | $8.38 | +222.20% | 5 | Aug 10, 2026 | |
| ORIC ORIC Pharmaceuticals | Reiterated: Buy | $25 → $27 | $13.87 | +94.66% | 49 | Aug 10, 2026 | |
| CGEM Cullinan Therapeutics | Reiterated: Buy | $30 | $20.34 | +47.49% | 11 | Aug 10, 2026 | |
| IMMX Immix Biopharma | Reiterated: Buy | $20 → $25 | $10.97 | +127.89% | 16 | Aug 10, 2026 | |
| NUVB Nuvation Bio | Reiterated: Buy | $21 | $6.22 | +237.62% | 34 | Aug 7, 2026 | |
| BDTX Black Diamond Therapeutics | Reiterated: Buy | $11 | $2.02 | +444.55% | 42 | Aug 6, 2026 | |
| KPTI Karyopharm Therapeutics | Downgraded: Hold | $13 → $3 | $2.02 | +48.51% | 11 | Jul 31, 2026 | |
| PRLD Prelude Therapeutics | Reiterated: Buy | $8 | $5.55 | +44.14% | 25 | Jul 29, 2026 | |
| OKUR OnKure Therapeutics | Reiterated: Buy | $27 → $21 | $3.99 | +426.32% | 8 | Jul 20, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $32 → $34 | $27.05 | +25.69% | 31 | Jul 10, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $7 | $2.57 | +172.37% | 23 | Jul 9, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $56 → $65 | $58.82 | +10.51% | 12 | Jul 9, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $195 | $203.71 | -4.28% | 46 | Jul 6, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $13 | $4.21 | +208.79% | 7 | Jul 6, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $56 | $51.24 | +9.29% | 25 | Jul 2, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $23 | $3.09 | +644.34% | 15 | Jun 22, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $55 | $37.93 | +45.00% | 27 | Jun 18, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $11 | $1.58 | +596.20% | 30 | Jun 16, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $27 → $66 | $25.60 | +157.81% | 22 | Jun 10, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Downgraded: Hold | n/a | $1.01 | - | 45 | Jun 8, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiated Coverage: Buy | $16 | $2.56 | +525.00% | 1 | Jun 4, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Rated: Buy | $33 → $35 | $24.93 | +40.39% | 3 | Jun 3, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $13 | $3.20 | +306.25% | 10 | Jun 1, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Downgraded: Hold | n/a | $0.963 | - | 13 | Jun 1, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $42 | $24.28 | +72.98% | 14 | Jun 1, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $7 | $3.35 | +108.96% | 4 | May 28, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $25 → $28 | $19.86 | +40.99% | 35 | May 26, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $44 | $29.51 | +49.10% | 17 | May 12, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Hold | n/a | $4.22 | - | 34 | May 7, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $29 | $9.06 | +220.09% | 7 | May 1, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $130 | $93.09 | +39.65% | 104 | Apr 27, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Hold | n/a | $4.46 | - | 23 | Apr 21, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $8 → $11 | $2.05 | +436.59% | 32 | Apr 16, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Downgraded: Sell | n/a | $14.97 | - | 44 | Apr 13, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Buy | $8 | $2.15 | +272.09% | 12 | Feb 13, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $10 | $2.47 | +304.86% | 7 | Feb 3, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $5 | $1.26 | +296.83% | 21 | Nov 12, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Hold | n/a | $8.09 | - | 29 | Aug 19, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Rated: Hold | n/a | $23.40 | n/a | 8 | Sep 3, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Rated: Hold | n/a | $0.0002 | n/a | 6 | Jul 16, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Rated: Hold | n/a | $0.296 | n/a | 19 | May 24, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $110 → $20 | $1.59 | n/a | 2 | Mar 21, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Downgraded: Hold | n/a | $0.1734 | n/a | 13 | Jan 8, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Hold | n/a | $36.14 | n/a | 18 | Mar 21, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $22 | $5.84 | n/a | 7 | Mar 17, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $11 | $3.36 | n/a | 15 | May 10, 2022 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Sell | n/a | $1.58 | n/a | 16 | Oct 22, 2021 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $10 | $1.59 | n/a | 8 | Mar 5, 2021 |
Zymeworks
Aug 10, 2026
Reiterated: Buy
Price Target: $51
Current: $25.12
Upside: +103.03%
Adicet Bio
Aug 10, 2026
Reiterated: Buy
Price Target: $27
Current: $8.38
Upside: +222.20%
ORIC Pharmaceuticals
Aug 10, 2026
Reiterated: Buy
Price Target: $25 → $27
Current: $13.87
Upside: +94.66%
Cullinan Therapeutics
Aug 10, 2026
Reiterated: Buy
Price Target: $30
Current: $20.34
Upside: +47.49%
Immix Biopharma
Aug 10, 2026
Reiterated: Buy
Price Target: $20 → $25
Current: $10.97
Upside: +127.89%
Nuvation Bio
Aug 7, 2026
Reiterated: Buy
Price Target: $21
Current: $6.22
Upside: +237.62%
Black Diamond Therapeutics
Aug 6, 2026
Reiterated: Buy
Price Target: $11
Current: $2.02
Upside: +444.55%
Karyopharm Therapeutics
Jul 31, 2026
Downgraded: Hold
Price Target: $13 → $3
Current: $2.02
Upside: +48.51%
Prelude Therapeutics
Jul 29, 2026
Reiterated: Buy
Price Target: $8
Current: $5.55
Upside: +44.14%
OnKure Therapeutics
Jul 20, 2026
Reiterated: Buy
Price Target: $27 → $21
Current: $3.99
Upside: +426.32%
Jul 10, 2026
Reiterated: Buy
Price Target: $32 → $34
Current: $27.05
Upside: +25.69%
Jul 9, 2026
Reiterated: Buy
Price Target: $7
Current: $2.57
Upside: +172.37%
Jul 9, 2026
Reiterated: Buy
Price Target: $56 → $65
Current: $58.82
Upside: +10.51%
Jul 6, 2026
Reiterated: Buy
Price Target: $195
Current: $203.71
Upside: -4.28%
Jul 6, 2026
Reiterated: Buy
Price Target: $13
Current: $4.21
Upside: +208.79%
Jul 2, 2026
Reiterated: Buy
Price Target: $56
Current: $51.24
Upside: +9.29%
Jun 22, 2026
Reiterated: Buy
Price Target: $23
Current: $3.09
Upside: +644.34%
Jun 18, 2026
Reiterated: Buy
Price Target: $55
Current: $37.93
Upside: +45.00%
Jun 16, 2026
Reiterated: Buy
Price Target: $11
Current: $1.58
Upside: +596.20%
Jun 10, 2026
Reiterated: Buy
Price Target: $27 → $66
Current: $25.60
Upside: +157.81%
Jun 8, 2026
Downgraded: Hold
Price Target: n/a
Current: $1.01
Upside: -
Jun 4, 2026
Initiated Coverage: Buy
Price Target: $16
Current: $2.56
Upside: +525.00%
Jun 3, 2026
Rated: Buy
Price Target: $33 → $35
Current: $24.93
Upside: +40.39%
Jun 1, 2026
Reiterated: Buy
Price Target: $13
Current: $3.20
Upside: +306.25%
Jun 1, 2026
Downgraded: Hold
Price Target: n/a
Current: $0.963
Upside: -
Jun 1, 2026
Reiterated: Buy
Price Target: $42
Current: $24.28
Upside: +72.98%
May 28, 2026
Reiterated: Buy
Price Target: $7
Current: $3.35
Upside: +108.96%
May 26, 2026
Reiterated: Buy
Price Target: $25 → $28
Current: $19.86
Upside: +40.99%
May 12, 2026
Reiterated: Buy
Price Target: $44
Current: $29.51
Upside: +49.10%
May 7, 2026
Reiterated: Hold
Price Target: n/a
Current: $4.22
Upside: -
May 1, 2026
Reiterated: Buy
Price Target: $29
Current: $9.06
Upside: +220.09%
Apr 27, 2026
Reiterated: Buy
Price Target: $130
Current: $93.09
Upside: +39.65%
Apr 21, 2026
Reiterated: Hold
Price Target: n/a
Current: $4.46
Upside: -
Apr 16, 2026
Reiterated: Buy
Price Target: $8 → $11
Current: $2.05
Upside: +436.59%
Apr 13, 2026
Downgraded: Sell
Price Target: n/a
Current: $14.97
Upside: -
Feb 13, 2026
Maintained: Buy
Price Target: $8
Current: $2.15
Upside: +272.09%
Feb 3, 2026
Reiterated: Buy
Price Target: $10
Current: $2.47
Upside: +304.86%
Nov 12, 2025
Reiterated: Buy
Price Target: $5
Current: $1.26
Upside: +296.83%
Aug 19, 2025
Reiterated: Hold
Price Target: n/a
Current: $8.09
Upside: -
Sep 3, 2024
Rated: Hold
Price Target: n/a
Current: $23.40
Upside: n/a
Jul 16, 2024
Rated: Hold
Price Target: n/a
Current: $0.0002
Upside: n/a
May 24, 2024
Rated: Hold
Price Target: n/a
Current: $0.296
Upside: n/a
Mar 21, 2024
Reiterated: Buy
Price Target: $110 → $20
Current: $1.59
Upside: n/a
Jan 8, 2024
Downgraded: Hold
Price Target: n/a
Current: $0.1734
Upside: n/a
Mar 21, 2023
Reiterated: Hold
Price Target: n/a
Current: $36.14
Upside: n/a
Mar 17, 2023
Reiterated: Buy
Price Target: $22
Current: $5.84
Upside: n/a
May 10, 2022
Reiterated: Buy
Price Target: $11
Current: $3.36
Upside: n/a
Oct 22, 2021
Maintained: Sell
Price Target: n/a
Current: $1.58
Upside: n/a
Mar 5, 2021
Reiterated: Buy
Price Target: $10
Current: $1.59
Upside: n/a